Protara Therapeutics, Inc. 1KPA.F Stock
Protara Therapeutics, Inc. Price Chart
Protara Therapeutics, Inc. 1KPA.F Financial and Trading Overview
| Protara Therapeutics, Inc. stock price | 2.86 EUR |
| Previous Close | 2.54 EUR |
| Open | 2.56 EUR |
| Bid | 2.56 EUR x N/A |
| Ask | 2.64 EUR x N/A |
| Day's Range | 2.56 - 2.56 EUR |
| 52 Week Range | 2.38 - 4.34 EUR |
| Volume | 2.2K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 29.22M EUR |
| Beta (5Y Monthly) | 1.547604 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.33 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40 EUR |
1KPA.F Valuation Measures
| Enterprise Value | -51727776 EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.49612403 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.30541638 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1.432 |
Trading Information
Protara Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.547604 |
| 52-Week Change | -10.41% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.34 EUR |
| 52 Week Low | 2.38 EUR |
| 50-Day Moving Average | 2.81 EUR |
| 200-Day Moving Average | 3.05 EUR |
1KPA.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 11.31M |
| Float | 6.2M |
| Short Ratio | N/A |
| % Held by Insiders | 16.66% |
| % Held by Institutions | 51.52% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.00000000000000000000000000000000% |
| Return on Equity (ttm) | -52.017% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -36134000 EUR |
| Net Income Avi to Common (ttm) | -64242000 EUR |
| Diluted EPS (ttm) | -5.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 86.61M EUR |
| Total Cash Per Share (mrq) | 7.66 EUR |
| Total Debt (mrq) | 6.16M EUR |
| Total Debt/Equity (mrq) | 6.5 EUR |
| Current Ratio (mrq) | 14.761 |
| Book Value Per Share (mrq) | 8.382 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28384000 EUR |
| Levered Free Cash Flow (ttm) | -17635876 EUR |
Profile of Protara Therapeutics, Inc.
| Country | Germany |
| State | NY |
| City | New York |
| Address | 345 Park Avenue South |
| ZIP | 10010 |
| Phone | 646 844 0337 |
| Website | https://www.protaratx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 25 |
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. The company is headquartered in New York, New York.
Q&A For Protara Therapeutics, Inc. Stock
What is a current 1KPA.F stock price?
Protara Therapeutics, Inc. 1KPA.F stock price today per share is 2.86 EUR.
How to purchase Protara Therapeutics, Inc. stock?
You can buy 1KPA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Protara Therapeutics, Inc.?
The stock symbol or ticker of Protara Therapeutics, Inc. is 1KPA.F.
Which industry does the Protara Therapeutics, Inc. company belong to?
The Protara Therapeutics, Inc. industry is Biotechnology.
How many shares does Protara Therapeutics, Inc. have in circulation?
The max supply of Protara Therapeutics, Inc. shares is 11.43M.
What is Protara Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Protara Therapeutics, Inc. PE Ratio is now.
What was Protara Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Protara Therapeutics, Inc. EPS is -3.33 EUR over the trailing 12 months.
Which sector does the Protara Therapeutics, Inc. company belong to?
The Protara Therapeutics, Inc. sector is Healthcare.